Related Experiment Video
Updated: Apr 12, 2026

07:20
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
15.4K
Summary
Naturally occurring allogeneic IgG antibodies were found to stimulate antitumor immunity and promote tumor rejection in mouse models. This discovery offers potential new avenues for cancer immunotherapy research.
Area of Science:
- Immunology
- Oncology
Background:
- Immunoglobulin G (IgG) antibodies play crucial roles in adaptive immunity.
- The potential of naturally occurring antibodies in cancer immunotherapy is an area of active investigation.
Purpose of the Study:
- To investigate the role of naturally occurring allogeneic IgG antibodies in inducing antitumor responses.
- To determine if these antibodies can mediate tumor rejection in vivo.
Main Methods:
- Administration of naturally occurring allogeneic IgG antibodies to tumor-bearing mice.
- Assessment of immune cell infiltration and cytokine production in the tumor microenvironment.
- Monitoring of tumor growth and survival rates.
Main Results:
- Allogeneic IgG antibodies significantly enhanced antitumor immunity.
- Treatment led to increased infiltration of immune cells and modulation of the tumor microenvironment.
- Tumor rejection and improved survival were observed in treated mice.
Conclusions:
- Naturally occurring allogeneic IgG antibodies can effectively induce antitumor immunity.
- These antibodies represent a promising therapeutic strategy for cancer treatment.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cell-mediated Immune Responses
87.6K
Overview
87.6K

